[1] |
López-Ruiz ME, Yébenes L, Berjón A, et al. Primary Leiomyosarcoma of the Ovarian Vein: Case Report and Literature Review[J]. Int J Surg Pathol, 2017, 25(4):339-343. doi: 10.1177/1066896916679888.
doi: 10.1177/1066896916679888
pmid: 27881610
|
[2] |
Honoré LH, Robins RE, Taylor RH. Leiomyosarcoma of the right ovarian vein a case report[J]. Angiology, 1977, 28(4):285-288. doi: 10.1177/000331977702800409.
doi: 10.1177/000331977702800409
pmid: 869287
|
[3] |
Kawai K, Horiguchi H, Sekido N, et al. Leiomyosarcoma of the ovarian vein: an unusual cause of severe abdominal and flank pain[J]. Int J Urol, 1996, 3(3):234-236. doi: 10.1111/j.1442-2042.1996.tb00523.x.
doi: 10.1111/j.1442-2042.1996.tb00523.x
pmid: 8776624
|
[4] |
Saigusa S, Ohi M, Inoue Y, et al. Preoperative diagnosis by three-dimensional angiography of a leiomyosarcoma arising from the left ovarian vein[J]. BMJ Case Rep, 2013, 2013:bcr2013008823. doi: 10.1136/bcr-2013-008823.
doi: 10.1136/bcr-2013-008823
|
[5] |
Cho HJ, Kim HK, Suh JH, et al. Leiomyosarcoma of the ovarian vein: a case report with radiological findings[J]. Korean J Radiol, 2008, 9(Suppl):S14-S17. doi: 10.3348/kjr.2008.9.s.s14.
doi: 10.3348/kjr.2008.9.s.s14
|
[6] |
Iannelli A, Karimdjee BS, Fabiani P, et al. Leiomyosarcoma of the ovarian vein: report of a case[J]. Int Surg, 2003, 88(1):6-8.
pmid: 12731723
|
[7] |
Chiarugi M, Pressi E, Mancini R, et al. Leiomyosarcoma of the right ovarian vein[J]. Am J Surg, 2009, 197(4):e36-e37. doi: 10.1016/j.amjsurg.2008.02.014.
doi: 10.1016/j.amjsurg.2008.02.014
|
[8] |
Tsuchiya H, Kawahara T, Kawai K, et al. A Case of Leiomyosarcoma Arising from the Ovarian Vein Preoperatively Diagnosed with Radiological Imaging[J]. Hinyokika Kiyo, 2017, 63(10):407-412. doi: 10.14989/ActaUrolJap_63_10_407.
doi: 10.14989/ActaUrolJap_63_10_407
pmid: 29103254
|
[9] |
Kim SH, Kwon HJ, Cho JH, et al. Atypical radiological features of a leiomyosarcoma that arose from the ovarian vein and mimicked a vascular tumour[J]. Br J Radiol, 2010, 83(989):e95-e97. doi: 10.1259/bjr/50917539.
doi: 10.1259/bjr/50917539
URL
|
[10] |
Tsuyoshi H, Yoshida Y, Kurokawa T, et al. Diagnosis and management of leiomyosarcoma arising from ovarian vein: case report and literature review[J]. J Obstet Gynaecol Res, 2012, 38(2):466-470. doi: 10.1111/j.1447-0756.2011.01725.x.
doi: 10.1111/j.1447-0756.2011.01725.x
URL
|
[11] |
Yang SH, Chien JC, Chen CL, et al. Leiomyosarcoma of ovarian vein compression as a cause of hydronephrosis[J]. Eur J Gynaecol Oncol, 2011, 32(3):336-338.
pmid: 21797130
|
[12] |
王超, 李宝忠. 卵巢静脉平滑肌肉瘤影像表现一例[J]. 中华放射学杂志, 2017, 51(6):466-467. doi: 10.3760/cma.j.issn.1005-1201.2017.06.016.
doi: 10.3760/cma.j.issn.1005-1201.2017.06.016
|
[13] |
Rajpurohit V, Mehta P, Kothari N, et al. Leiomyosarcoma of the Right Ovarian Vein: a Case Report with Multimodality Management and Long-Term Follow-Up[J]. Indian J Surg Oncol, 2019, 10(3):523-526. doi: 10.1007/s13193-019-00936-3.
doi: 10.1007/s13193-019-00936-3
URL
|
[14] |
Hirano T, Okumura H, Maeda S, et al. Vascular leiomyosarcoma originating from the right ovarian vein: a case report and literature review[J]. Surg Case Rep, 2019, 5(1):120. doi: 10.1186/s40792-019-0679-5.
doi: 10.1186/s40792-019-0679-5
pmid: 31342204
|
[15] |
Suzuki K, Taniguchi K, Ito S, et al. Leiomyosarcoma arising from the right ovarian vein[J]. J Surg Case Rep, 2019, 2019(11): rjz302. doi: 10.1093/jscr/rjz302.
doi: 10.1093/jscr/rjz302
|
[16] |
Kozłowski M, Nowak K, Kordek A, et al. Therapeutic Management of Rare Primary Ovarian Neoplasms: Carcinosarcoma, Leiomyosarcoma, Melanoma and Carcinoid[J]. Int J Environ Res Public Health, 2021, 18(15):7819. doi: 10.3390/ijerph18157819.
doi: 10.3390/ijerph18157819
URL
|
[17] |
Kasper B, D′Ambrosio L, Davis EJ, et al. What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?[J]. Curr Treat Options Oncol, 2022, 23(3):439-449. doi: 10.1007/s11864-021-00928-y.
doi: 10.1007/s11864-021-00928-y
URL
|
[18] |
Devaud N, Vornicova O, Abdul Razak AR, et al. Leiomyosarcoma: Current Clinical Management and Future Horizons[J]. Surg Oncol Clin N Am, 2022, 31(3):527-546. doi: 10.1016/j.soc.2022.03.011.
doi: 10.1016/j.soc.2022.03.011
pmid: 35715148
|
[19] |
D′Ambrosio L, Touati N, Blay JY, et al. Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group[J]. Cancer, 2020, 126(11):2637-2647. doi: 10.1002/cncr.32795.
doi: 10.1002/cncr.32795
pmid: 32129883
|
[20] |
Novotny JP, George S. Leiomyosarcoma: Does Location of Primary Help to Determine the Best Systemic Therapy Options?[J]. Curr Treat Options Oncol, 2021, 22(11):99. doi: 10.1007/s11864-021-00897-2.
doi: 10.1007/s11864-021-00897-2
URL
|